ArticleMolecular therapy : the journal of the American Society of Gene Therapy2024
RNA therapeutics targeting PD-L1 is a promising immune-activation strategy against difficult-to-treat cancers.
Li Ding et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.